ladiratuzumab vedotin plus pembrolizumab for advanced tnbc
Published 3 years ago • 36 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
3:26
dr. sara tolaney on eribulin plus pembrolizumab for metastatic triple-negative breast cancer
-
4:53
pembrolizumab with chemotherapy for tnbc
-
3:49
pembrolizumab with radiation therapy for patients with triple negative breast cancer
-
5:34
secondary endpoints from a trial of pembrolizumab plus chemotherapy for metastatic tnbc
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
1:36
dr. hurvitz on pembrolizumab for tnbc
-
0:58
dr. nanda on pembrolizumab potential for tnbc
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
1:07
phase ii results for pembrolizumab monotherapy in metastatic tnbc
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
1:58
ascent-04: sacituzumab govitecan and pembrolizumab in pd-l1-positive tnbc
-
6:10
pd-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
12:45
keynote-355: first-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
4:19
antibody drug conjugates for triple negative breast cancer: targeting positive in the negative
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc